Iovance Biotherapeutics (IOVA) Research & Development (2016 - 2025)
Historic Research & Development for Iovance Biotherapeutics (IOVA) over the last 10 years, with Q3 2025 value amounting to $75.2 million.
- Iovance Biotherapeutics' Research & Development rose 1213.97% to $75.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $308.5 million, marking a year-over-year increase of 410.23%. This contributed to the annual value of $282.3 million for FY2024, which is 1794.39% down from last year.
- Per Iovance Biotherapeutics' latest filing, its Research & Development stood at $75.2 million for Q3 2025, which was up 1213.97% from $79.4 million recorded in Q2 2025.
- Iovance Biotherapeutics' Research & Development's 5-year high stood at $87.5 million during Q3 2023, with a 5-year trough of $62.1 million in Q2 2024.
- For the 3-year period, Iovance Biotherapeutics' Research & Development averaged around $78.3 million, with its median value being $79.4 million (2025).
- In the last 5 years, Iovance Biotherapeutics' Research & Development crashed by 2809.94% in 2024 and then surged by 2783.16% in 2025.
- Quarter analysis of 3 years shows Iovance Biotherapeutics' Research & Development stood at $87.5 million in 2023, then decreased by 11.84% to $77.1 million in 2024, then decreased by 2.52% to $75.2 million in 2025.
- Its Research & Development stands at $75.2 million for Q3 2025, versus $79.4 million for Q2 2025 and $76.9 million for Q1 2025.